Latest filing published 05 Aug 2026 for Teva Pharmaceutical Industries Ltd.
Eric A. Hughes is listed at Teva Pharmaceutical Industries Ltd under the role See "Remarks", in 24 filings published from 2023 to 2026. Nothing indicates a purchase. The record holds 11 option exercises and 13 sales, worth EUR 5.8 million in total with a median of EUR 315,229.
The largest sale, EUR 1,900,141, is dated March 3, 2026. The next two are EUR 717,288 on August 9, 2024 and EUR 699,918 on August 1, 2025: all three fall in early August.
Filings go from 2 in 2023 to 5 in 2024, 8 in 2025 and 9 in 2026. Those 9 filings are the only ones in the last twelve months, and none is a sale. Publication takes a median of 2 days.
Within 30 days of colleagues at Teva Pharmaceutical Industries Ltd, Hughes has 11, 10 and 9 own market trades, in that order. All on the same side. Colleagues in order: Richard Daniell, Eliyahu Sharon Kalif and Mark Sabag.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations